PS Therapeutique  is a specialty Contract Research Organization which dedicates its expertise and technology to the evaluation of the efficacy and safety of new drugs during the Discovery stage of their development, by using validated and highly predictive models. Recognized for the quality and the on-time delivery of its preclinical studies, IPS Therapeutique addresses the particular needs of start-up and mature biopharmaceutical companies which are looking for fast and cost-effective solutions to demonstrate the potency of their preclinical candidates.